Estradiol 3-benzoate 17β-butyrate is a synthetic steroid ester derivative of estradiol, the primary female sex hormone. It is formed by esterifying the phenolic hydroxyl group at the 3-position with benzoic acid and the hydroxyl group at the 17β-position with butyric acid. This dual esterification modifies the physicochemical properties, particularly the lipophilicity and pharmacokinetic profile, compared to the parent estradiol. This compound is primarily utilized as a pharmaceutical intermediate or a prodrug in the development of hormone replacement therapies (HRT) and other estrogen-based medications. The ester groups serve to enhance lipid solubility, potentially allowing for sustained release from depot formulations after intramuscular injection, thereby prolonging the duration of estrogenic activity in the body. It is a key synthetic building block for creating novel estrogen derivatives with tailored release characteristics and metabolic stability. As a steroid derivative, it is handled as a potent active pharmaceutical ingredient (API) intermediate. Relevant safety data and handling procedures should be consulted prior to use, as it may exhibit estrogenic biological activity.